These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23170077)

  • 1. Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.
    Costa M; Costa-Rodrigues J; Fernandes MH; Barros P; Vasconcelos V; Martins R
    Mar Drugs; 2012 Oct; 10(10):2181-2207. PubMed ID: 23170077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyanobacteria derived compounds: Emerging drugs for cancer management.
    Shahid A; Khurshid M; Aslam B; Muzammil S; Mehwish HM; Rajoka MSR; Hayat HF; Sarfraz MH; Razzaq MK; Nisar MA; Waseem M
    J Basic Microbiol; 2022 Sep; 62(9):1125-1142. PubMed ID: 34747529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Compounds from Cyanobacteria and their Implications in Apoptosis.
    Gupta A; Singh PR; Singh AP; Kumari N; Jaiswal J; Sahu N; Mishra S; Pathak J; Sinha RP
    Curr Protein Pept Sci; 2023; 24(10):805-819. PubMed ID: 37055887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors.
    Qamar H; Hussain K; Soni A; Khan A; Hussain T; Chénais B
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33466486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyanobacteria as a Source for Novel Anti-Leukemic Compounds.
    Humisto A; Herfindal L; Jokela J; Karkman A; Bjørnstad R; Choudhury RR; Sivonen K
    Curr Pharm Biotechnol; 2016; 17(1):78-91. PubMed ID: 26306745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites.
    Nagarajan M; Maruthanayagam V; Sundararaman M
    J Appl Toxicol; 2012 Mar; 32(3):153-85. PubMed ID: 21910132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine Cyanobacteria and Microalgae Metabolites-A Rich Source of Potential Anticancer Drugs.
    Mondal A; Bose S; Banerjee S; Patra JK; Malik J; Mandal SK; Kilpatrick KL; Das G; Kerry RG; Fimognari C; Bishayee A
    Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32961827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Diversity, Biological Properties and Applications of Natural Products from Cyanobacteria. A Review.
    Shah SAA; Akhter N; Auckloo BN; Khan I; Lu Y; Wang K; Wu B; Guo YW
    Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29125580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive natural products from marine cyanobacteria for drug discovery.
    Tan LT
    Phytochemistry; 2007 Apr; 68(7):954-79. PubMed ID: 17336349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marine Cyanobacteria as Sources of Lead Anticancer Compounds: A Review of Families of Metabolites with Cytotoxic, Antiproliferative, and Antineoplastic Effects.
    Robles-Bañuelos B; Durán-Riveroll LM; Rangel-López E; Pérez-López HI; González-Maya L
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marine benthic cyanobacteria contain apoptosis-inducing activity synergizing with daunorubicin to kill leukemia cells, but not cardiomyocytes.
    Oftedal L; Selheim F; Wahlsten M; Sivonen K; Døskeland SO; Herfindal L
    Mar Drugs; 2010 Oct; 8(10):2659-72. PubMed ID: 21116413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immense essence of excellence: marine microbial bioactive compounds.
    Bhatnagar I; Kim SK
    Mar Drugs; 2010 Oct; 8(10):2673-701. PubMed ID: 21116414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring bioactive properties of marine cyanobacteria isolated from the Portuguese coast: high potential as a source of anticancer compounds.
    Costa M; Garcia M; Costa-Rodrigues J; Costa MS; Ribeiro MJ; Fernandes MH; Barros P; Barreiro A; Vasconcelos V; Martins R
    Mar Drugs; 2013 Dec; 12(1):98-114. PubMed ID: 24384871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioprospecting Sponge-Associated Marine Cyanobacteria to Produce Bioactive Compounds.
    Konstantinou D; Mavrogonatou E; Zervou SK; Giannogonas P; Gkelis S
    Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 31979262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dereplication of Natural Products with Antimicrobial and Anticancer Activity from Brazilian Cyanobacteria.
    Shishido TK; Popin RV; Jokela J; Wahlsten M; Fiore MF; Fewer DP; Herfindal L; Sivonen K
    Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31878347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytoplankton of the Curonian Lagoon as a New Interesting Source for Bioactive Natural Products. Special Impact on Cyanobacterial Metabolites.
    Overlingė D; Toruńska-Sitarz A; Cegłowska M; Błaszczyk A; Szubert K; Pilkaitytė R; Mazur-Marzec H
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of cancer cells' proliferation by compounds included in extracts from Baltic Sea cyanobacteria.
    Felczykowska A; Pawlik A; Mazur-Marzec H; Toruńska-Sitarz A; Narajczyk M; Richert M; Węgrzyn G; Herman-Antosiewicz A
    Toxicon; 2015 Dec; 108():1-10. PubMed ID: 26410109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring marine cyanobacteria for lead compounds of pharmaceutical importance.
    Uzair B; Tabassum S; Rasheed M; Rehman SF
    ScientificWorldJournal; 2012; 2012():179782. PubMed ID: 22545008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical agents from filamentous marine cyanobacteria.
    Tan LT
    Drug Discov Today; 2013 Sep; 18(17-18):863-71. PubMed ID: 23711931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in chemistry and bioactivity of marine cyanobacteria Moorea species.
    Xu J; Zhang T; Yao J; Lu J; Liu Z; Ding L
    Eur J Med Chem; 2020 Sep; 201():112473. PubMed ID: 32652435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.